Perigord | Life Science Artwork Solutions


Perigord is the global leader in the provision of high quality artwork and labelling outsource services and management solutions to the Life Science industries.

Perigord partners with GlobalVision to integrate artwork management solutions.

Wednesday, September 07, 2016

Perigord partners with GlobalVision to integrate artwork management solutions.

Dublin, Ireland, September 7, 2016.

Perigord, innovators in Life Science Artwork Management Services and Solutions, and GlobalVision, leaders in the design and delivery of Innovative Proofreading Technologies, today announced their alliance for the integration of their artwork management systems in order to better service the Life Science Industries.

Perigord, recognising the value of working with GlobalVision, who have over 25 years’ experience in proofreading, has entered this strategic collaboration to enable seamless integration of GlobalVision’s Proofware software into their GLAMS (Global Artwork Management System) solution, resulting in streamlined exchanges and decreased time to market in the artwork processes.

Perigord’s GLAMS is a Configurable Off the Shelf (COTS) solution for Artwork Management that meets the current and future needs of Life Science customers.  GlobalVision’s Proofware brings an advanced suite of application tools focused on delivering accuracy and traceability for Quality Control, reducing artwork rework cycles and cost. Through the integration of these software management systems, the user will benefit from quicker file comparisons during proofreading, improved quality control and earlier error detection.  In addition, both systems facilitate 21 CFR Part 11 compliance to electronic records and electronic signature rules.

"We are excited to team with GlobalVision as they, like us, are specialists in the Life Science Industries and understand the GMP environment”, says Alan Leamy, CEO Perigord.  “As one of our new partners, GlobalVision represent our belief that the future of artwork management through the lifecycle process requires integrated automated technologies as a necessity of providing accurate artwork to market, on time and right first time.”

Jonathan Hou, Director of Technology at GlobalVision, also comments: “At GlobalVision, we are looking forward to the synergy this strategic partnership can bring to current and future clients, and we recognize that Perigord’s business mission fits very well with that of our Life Science focus.”

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally. Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle. 


Mark Ennis

Contact Us

About GlobalVision

GlobalVision is the world leader in the design of innovative proofreading technologies. With over 25 years of experience, we've helped customers increase proofreading accuracy, efficiency, and speed. Our solutions have been integrated into the packaging workflows of leading consumer packaged goods companies, printing firms and over 70% of the top pharmaceutical companies worldwide.


Michael Malz

Contact GlobalVision

Perigord explains the importance of compliant, validated artwork and labelling solutions in the pharmaceutical sector

Tuesday, April 12, 2016

The number of pharmaceutical product recalls are growing. Some estimates show that over 50% of recalls are related to pharmaceutical packaging artwork and labelling.

How many times have we heard these statistics over the last 20 years? And yet nothing changes.

The bottom line is that if there is an error with pharmaceutical artwork, the patient can die. The absence of regulatory requirements within the pharmaceutical industry regarding the production of artwork is indicative of the lack of focus often given to this process.

There is increased pressure to improve operational performances and reduce the level of human error. If we make it easy for someone to make a mistake, they will. We need to make it easy to get it right first time.

To do this we have to take a realistic look at the challenges faced by the pharmaceutical industry over the next five to ten years which will impact the artwork process and determine what robust innovative measures we should take to ensure these recall figures don’t spiral out of control.

Attitudes towards artwork management within the supply chain need to change. There should be a focus on quality driven systems to enable continuous technological developments facilitate the automation and standardisation required to prevent mistakes.

Industry analysis

Firstly we need to look at some of the key aspects of the pharmaceutical industry that are driving change.

1. Mergers & Acquisitions in the healthcare sector set a new record in 2015 of $724 billion. As a result, the agile and secure management of digital artwork assets has become a key strategic focus. 

2. Serialisation will result in a combination of more artwork content and stricter directives governing readability. This combined with reduced print space will drive an unprecedented demand for regulated artwork services and management systems over the next 5 years. 

3. Product proliferation leads to significantly increased frequency of artworking events and far greater complexities in managing the artworking processes with many companies having reached or exceeded their capability to manage the process internally. 

4. As a result of the patent cliff, a single innovative pharmaceutical product which has lost patent protection is being replaced with new generic products globally, leading to an exponential growth in demand for outsourced artwork solutions. 

What needs to be done?

Why do we accept high levels of inaccuracy when we can standardise how artwork is created and automate how it’s managed?

Pharmaceutical companies need to understand how their present artwork processes should change to facilitate these future drivers. To navigate accurately through these changes a proactive and systematic approach to artwork is crucial. Companies have to ask themselves if the artwork process is clearly defined, optimised and quality driven.

Managing artwork for the pharmaceutical industry is a very specialised, niche service which can only be properly controlled by a GMP compliant partner. If using a vendor, it is critical to develop a partnership to ensure all aspects of the artwork supply chain are controlled and agile to meet the challenges of the industry.

The two fundamental areas which need to be addressed are the physical production of the artwork and the management of the artwork process.

Artwork production 

Perigord recommends a one touch process in building compliant artwork which increases efficiency, reduces costs and minimises risk through fewer stages, thus eliminating the historical prepress stage. Effectively this means that artwork is built to high quality standards (and print ready) and the layer structure and font integrity is maintained throughout the approval cycle. Perigord ensures this process sits in a robust quality management system with a change management procedure that facilitates the efficiencies to be gained through the introduction of automated technology. 

Artwork management systems 

The most obvious way to remove the dangers of human error is to automate. Managing the amount of stakeholders and the input they have in this complex process by email is inconsistent with every company’s objective of getting product to market on time and right first time. This needs to be replaced by a highly configurable system that can be easily adapted to align with a customer's current and future processes, giving the flexibility of a systematic approach to managing products and product related information. 

In summary, reducing the number of recalls in the pharmaceutical industry requires better regulation, improved operational procedures and a change of attitude towards artwork production and management. The challenges that lie ahead have been identified, all we need now is to face them head on, in a controlled GMP fashion.


1 -

2 - 

Ireland’s Perigord Group first to achieve new quality standard

Tuesday, July 31, 2012

Perigord Group, a global artwork production agency has become the first company in Europe to be certified to PS 9000:2011 for software design and development.  

Dublin, Ireland, 31 July 2012. Perigord Group, a global artwork production agency has become the first company in Europe to be certified to PS 9000:2011 for software design and development. PS9000:2011 has been developed by the Pharmaceutical Quality Group for suppliers of packaging materials and origination/artwork to the pharmaceutical industry.

In addition to software design and development, Perigord’s PS9000:2011 accreditation also covers artwork services, lithographic and digital printing and direct mailing enabling them to offer a unique combined service package to the sector.

According to group’s quality manager Suzanne Ivory, ‘the introduction of artwork management software solutions coupled with innovative artwork services has been a game changer for the pharmaceutical & healthcare industry. At a time when pharmaceutical companies are competing more aggressively for market share, particularly in emerging markets, artwork management software leverages the inherent efficiencies of the internet in a new generation packaging solution that provides pharmaceuticals companies with greater cost efficiencies, reduced lead times and reduced risk of product recall.’

Perigord’s flagship software product GLAMS is a web-based Artwork Management System that was developed to manage and streamline the artwork process from concept through to printing. It places total control over artwork in the customer’s hands, enabling better management of costs and accelerating the customer’s time to market.

GLAMS creates a central online storage area that accepts all files using recognised industry standards, to provide a single point of proof. The system allows all involved parties to participate directly in the labelling and packaging lifecycle to generate artwork in a unified tracking and management flow. GLAMS integrates with all aspects of the artwork life cycle according to and in compliance with relevant industry standards and the customer’s specific needs.

The Perigord group now deliver global services from three artwork hubs, strategically located in Dublin, Connecticut and Singapore which enables them to deliver a 24/7 ‘follow the sun’ service. Their range of artwork services include production & change management, design & creation, image retouching & manipulation, advert creation & digital distribution, automatic artwork generation and template creation and management.


About the Perigord Group

Founded in 1976, the Perigord Group now provides high quality, cost efficient artwork services and software to many leading pharmaceutical & healthcare companies. With headquarters in Dublin, Ireland, and with artwork production hubs in Dublin, Connecticut & Singapore and sales offices in Sacramento, USA, Christchurch, New Zealand and Sao Paulo, Brazil the group’s pharmaceutical and healthcare customers now account for in excess of 70% of its annual revenue.

For further information,
Contact Us

Recent Posts



Centralised Global QMS Certified to ISO 9001:2015 & PS 9000:2016